It was recently suggested that triggering final oocyte maturation with GnRH-a versus hCG in IVM cycles among breast cancer patients undergoing fertility preservation could be beneficial, as evidenced by the number of mature oocytes and cryopreserved embryos [7]. This evidence concerns the gene GNRH1 and breast cancer.